Joshua Schechter - Feb 1, 2024 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Role
Director
Signature
/s/ Aaron Perlitsh, Attorney-In-Fact for Joshua Schechter
Stock symbol
LFCR
Transactions as of
Feb 1, 2024
Transactions value $
$0
Form type
4
Date filed
2/2/2024, 07:02 PM
Previous filing
Jun 5, 2023
Next filing
Mar 5, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFCR Common Stock Options Exercise +9.55K +19.86% 57.7K Feb 1, 2024 Direct F1
holding LFCR Common Stock 2K Feb 1, 2024 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LFCR Restricted Stock Units Options Exercise $0 -9.55K -100% $0.00* 0 Feb 1, 2024 Common Stock 9.55K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2 The restricted stock units vested on February 1, 2024.